Resectable pancreatic small cell carcinoma

by Dana K. Andersen, Robert C. Miller, Ralph H. Hruban, Matthew T. Olson, Fred E. Eckhauser, Dan Laheru, John L. Cameron, Joseph M. Herman, Amol K. Narang, Aaron S. Mansfield, Jordan M. Winter
Published 2011-03-01

Clinicopathological features and surgical outcomes of resected functional pancreatic neuroendocrine tumors: a single institution experience

by Ammar A. Javed, MD, Alina Hasanain, MD, Aleezay Haider, George Jones, BS, Zunaira N. Javed, Kevin Soares, MD, Richard A. Burkhart, MD, John L. Cameron, MD, FACS, Matthew J. Weiss, MD, FACS, Christopher L. Wolfgang, MD, PhD, FACS, Jin He, MD, PhD, FACS
Published 2019-06-01

Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers

by Kathryn J. Schunke, PhD, Lauren M. Rosati, BS, Marianna Zahurak, MS, Joseph M. Herman, MD, MSc, Amol K. Narang, MD, Irina Usach, Alison P. Klein, MHS, PhD, Charles J. Yeo, MD, Larry T. Korman, BSN, Ralph H. Hruban, MD, John L. Cameron, MD, Daniel A. Laheru, MD, Ross A. Abrams, MD
Published 2018-01-01